V souladu s legislativou České republiky poskytuje Společnost služby pouze kvalifikovaným investorům!

Cyteir Therapeutics. Financial results for the second quarter of 2021.

10.08.2021

GAAP net loss is -$4,83, which is $3,18 less than the same period last year.

The cash position of $198.6 million will be used to achieve expectative highlight figures of value creation and financial operations until 2023.